search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
ORLANDO, FL: MAY 13–16


Gastroenterology procedure demand will be robust over the next decade, driven by increases in upper GI endos- copy to diagnose and treat esophageal diseases, including gastroesophageal reflux as a result of obesity. Direct-to- consumer stool-based screening tests, e.g., Cologuard, and increasing aware- ness of young-onset colorectal cancer will drive volumes in diagnostic ser- vices, e.g., colonoscopy, sigmoidoscopy. Urology will see a significant shift


in volume from the inpatient to outpa- tient settings, driven by improvements in minimally invasive and noninvasive treatments for various urological condi- tions. The overall demand for urologi- cal services also will also increase dur- ing this time as the US population ages. The growing older population and


prevalence of chronic conditions, such as diabetes, will drive up demand for


Inpatient procedure volumes will remain flat over the coming decade but all ambulatory sites, including hospital outpatient departments and ASCs,will experience robust expansion.”


—Amanda Olderog, Sg2


outpatient ophthalmology services by 18 percent by 2029, predominantly among patients covered by Medicare and Medicare Advantage. Prevalence of age-related macular degeneration, cata- racts and glaucoma will rise. Demand for chronic eye disease services also will increase due to diabetic retinopa- thy, which affects approximately one in three diabetic patients.


Sg2 analysis finds that approxi- mately 50 percent of outpatient ortho- pedic procedures comfortably per- formed in the ASC setting—e.g., carpal tunnel release, trigger fin- ger release, anterior cruciate liga- ment repair—continue to be per- formed in the HOPD. The proportion of orthopedic procedures performed in the ASC is poised to grow rapidly as payment barriers for total joint replace- ment in the ASC diminish, bundled payment and value-based care efforts escalate, and quality comparisons between the ASC and HOPD arise to challenge the HOPD price differential. I look forward to discussing more


at ASCA 2020.


Amanda Olderog is a senior consulting director at Sg2 in Skokie, Illinois. Write her at AOlderog@sg2.com.


ASC FOCUS JANUARY 2020 | ascfocus.org


11


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38